Getinge reported another poor quarter, with Q1 16 numbers (both top line and bottom line) coming well below consensus estimates. Net sales were down 5% yoy to SEK6.4bn (-3% on an organic basis), while the order intake declined 4% to SEK6.9bn (-2% on an organic basis) mainly due to the continued weak demand for the capital goods business. The order intake in both Surgical Workflows and Patient & Post-Acute Care segments decreased 5%, while the sales decline was 7% and 5%, respectively (on
24 May 2016
Soft start to the year; still no clarity on Hechingen plant
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Soft start to the year; still no clarity on Hechingen plant
Getinge AB Class B (GTN:FRA) | 0 0 0.9% | Mkt Cap: 25,911m
- Published:
24 May 2016 -
Author:
Jyoti Prakash -
Pages:
3
Getinge reported another poor quarter, with Q1 16 numbers (both top line and bottom line) coming well below consensus estimates. Net sales were down 5% yoy to SEK6.4bn (-3% on an organic basis), while the order intake declined 4% to SEK6.9bn (-2% on an organic basis) mainly due to the continued weak demand for the capital goods business. The order intake in both Surgical Workflows and Patient & Post-Acute Care segments decreased 5%, while the sales decline was 7% and 5%, respectively (on